Some time ago, our team developed a monoclonal antibody specific against ANXA3. We are happy to share that after years of work, we have successfully obtained two US patents for the use of this antibody for HCC detection, prognosis and therapy (US 9,487,831 granted November 2016 and US 10,000,558 granted June 2018). Congrats to the 3 inventors on the patents – Stephanie Ma, Man Tong and Xin-Yuan Guan!
-
Follow
Following
Already have a WordPress.com account? Log in now.
The SMA Lab 